These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 25839217)
1. Biodegradable polymeric microsphere-based vaccines and their applications in infectious diseases. Lin CY; Lin SJ; Yang YC; Wang DY; Cheng HF; Yeh MK Hum Vaccin Immunother; 2015; 11(3):650-6. PubMed ID: 25839217 [TBL] [Abstract][Full Text] [Related]
2. Biodegradable polymer microspheres as vaccine adjuvants and delivery systems. Gupta RK; Chang AC; Siber GR Dev Biol Stand; 1998; 92():63-78. PubMed ID: 9554260 [TBL] [Abstract][Full Text] [Related]
3. Biodegradable polylactide microspheres enhance specific immune response induced by Hepatitis B surface antigen. Qiu S; Wei Q; Liang Z; Ma G; Wang L; An W; Ma X; Fang X; He P; Li H; Hu Z Hum Vaccin Immunother; 2014; 10(8):2350-6. PubMed ID: 25424942 [TBL] [Abstract][Full Text] [Related]
4. Poly(lactic acid) and poly(lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery. Pavot V; Berthet M; Rességuier J; Legaz S; Handké N; Gilbert SC; Paul S; Verrier B Nanomedicine (Lond); 2014 Dec; 9(17):2703-18. PubMed ID: 25529572 [TBL] [Abstract][Full Text] [Related]
5. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres. Jaganathan KS; Rao YU; Singh P; Prabakaran D; Gupta S; Jain A; Vyas SP Int J Pharm; 2005 Apr; 294(1-2):23-32. PubMed ID: 15814228 [TBL] [Abstract][Full Text] [Related]
6. [Controlled release antigen from the injection site--new model for a single-shot vaccination?]. Gałazka A; Wysokińska T Postepy Hig Med Dosw; 1998; 52(2):157-72. PubMed ID: 9640979 [TBL] [Abstract][Full Text] [Related]
7. An experimental divalent vaccine based on biodegradable microspheres induces protective immunity against tetanus and diphtheria. Peyre M; Sesardic D; Merkle HP; Gander B; Johansen P J Pharm Sci; 2003 May; 92(5):957-66. PubMed ID: 12712415 [TBL] [Abstract][Full Text] [Related]
9. On technological and immunological benefits of multivalent single-injection microsphere vaccines. Boehm G; Peyre M; Sesardic D; Huskisson RJ; Mawas F; Douglas A; Xing D; Merkle HP; Gander B; Johansen P Pharm Res; 2002 Sep; 19(9):1330-6. PubMed ID: 12403070 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of protective efficacy using a nonstructural protein NS1 in DNA vaccine-loaded microspheres against dengue 2 virus. Huang SS; Li IH; Hong PD; Yeh MK Int J Nanomedicine; 2013; 8():3161-9. PubMed ID: 23990724 [TBL] [Abstract][Full Text] [Related]
15. Biodegradable particles as vaccine antigen delivery systems for stimulating cellular immune responses. Joshi VB; Geary SM; Salem AK Hum Vaccin Immunother; 2013 Dec; 9(12):2584-90. PubMed ID: 23978910 [TBL] [Abstract][Full Text] [Related]
16. Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination. Johansen P; Men Y; Merkle HP; Gander B Eur J Pharm Biopharm; 2000 Jul; 50(1):129-46. PubMed ID: 10840197 [TBL] [Abstract][Full Text] [Related]
17. Biodegradable poly-l-lactide based microparticles as controlled release delivery system for filarial vaccine candidate antigens. Anugraha G; Madhumathi J; Jeya Prita PJ; Kaliraj P Eur J Pharmacol; 2015 Jan; 747():174-80. PubMed ID: 25514604 [TBL] [Abstract][Full Text] [Related]
18. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. America Academy of Pediatrics Commitee on Infectious Diseases Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131 [TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of pulsatile-release PLGA microspheres for single-injection vaccination. Guarecuco R; Lu J; McHugh KJ; Norman JJ; Thapa LS; Lydon E; Langer R; Jaklenec A Vaccine; 2018 May; 36(22):3161-3168. PubMed ID: 28625520 [TBL] [Abstract][Full Text] [Related]